Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 601 to 650 of 1444 results for nice quality standards or clinical guidelines

  1. Antimicrobial stewardship

    All NICE products on antimicrobial stewardship. Includes any guidance, advice and quality standards.

  2. 'Transfuse and Check' – improving post-operative blood transfusion in line with NICE guidance

    'Transfuse and Check'. The NICE guidance on transfusion, NICE NG24, was published in November 2015. There are 3...

  3. Integrated Care Clinical Pharmacist for Frail Older People: Case Management and Enhanced Rapid Response

    2015 The Integrated Care Clinical Pharmacist (ICP) is an innovative community based role where pharmacists

  4. Community engagement: improving health and wellbeing and reducing health inequalities (NG44)

    This guideline covers community engagement approaches to reduce health inequalities, ensure health and wellbeing initiatives are effective and help local authorities and health bodies meet their statutory obligations.

  5. Improving young people's experiences in transition to and from inpatient mental health settings

    A quick guide for mental health practitioners supporting young people transitioning to and from inpatient mental health settings

  6. Patient and public involvement policy

    NICE's approach to patient and public involvement is based on 2 key principles: that lay people, and organisations representing their...

  7. Spasticity in under 19s: management (CG145)

    This guideline covers managing spasticity and co-existing motor disorders and their early musculoskeletal complications in children and young people (from birth up to their 19th birthday) with non-progressive brain disorders. It aims to reduce variation in practice and help healthcare professionals to select and use appropriate treatments.

  8. Looked-after children and young people (NG205)

    This guideline covers how organisations, practitioners and carers should work together to deliver high-quality care, stable placements and nurturing relationships for looked-after children and young people. It aims to help these children and young people reach their full potential and have the same opportunities as their peers.

  9. NICE decision aid: process guide (PMG42)

    NICE decision aid: process guide

  10. NICE impact people with a learning disability

    Coleman considers the role of NICE in improving outcomes for people with a learning disability. "We welcome the commitment from...

  11. Get involved

    We want you to tell us what matters to you, your organisation or your community.

  12. Type 2 diabetes prevention: population and community-level interventions (PH35)

    This guideline covers preventing type 2 diabetes in adult populations and communities who are at high risk. It aims to promote a healthy diet and physical activity at community and population level, and recommends how to tailor services for people in ethnic communities and other groups who are particularly at risk of type 2 diabetes.

  13. Developing a medications policy and procedures for use in social care

    procedure are aligned with the recommended standards outlined in NICE Guidance 67 and NICE...

  14. Cellulitis and erysipelas: antimicrobial prescribing (NG141)

    This guideline sets out an antimicrobial prescribing strategy for adults, young people, children and babies aged 72 hours and over with cellulitis and erysipelas. It aims to optimise antibiotic use and reduce antibiotic resistance.

  15. Intermediate care including reablement

    up for me and a toilet seat. I felt much safer. Later in the day a really nice carer with a big smile on his face came in and said he...

  16. Enabling positive lives for autistic adults

    A quick guide to enabling positive lives for autistic adults for social workers.

  17. Managing long-term conditions in the community

    NICE's impact on managing long-term conditions in children in the community

  18. Good practice guidance – Integrated process statement (PMG12)

    Good practice guidance – Integrated process statement

  19. People's experience of care and support

    The section of the NICEimpact report on social care that looks at people's experience of care and support

  20. Challenging assumptions and improving people's quality of life within a large social care provider organisation

    This project sought to implement and embed the NICE guideline (NG11) & Quality Standard (QS101) regarding learning disability and challenging behaviour within a large social care provider organisation

  21. Panobinostat for treating multiple myeloma after at least 2 previous treatments (TA380)

    Evidence-based recommendations on panobinostat (Farydak) for treating multiple myeloma after at least 2 previous treatments.

  22. Diagnosis and referral of inflammatory arthritis

    our guideline on RArheumatoid arthritis and guideline on SpAspondyloarthritis . To ensure an accurate and timely diagnosis,...

  23. Trifluridine–tipiracil for previously treated metastatic colorectal cancer (TA405)

    Evidence-based recommendations on trifluridine–tipiracil (Lonsurf) for previously treated metastatic colorectal cancer in adults.

  24. Supporting the health and care system to implement virtual wards

    Dr Bushra Alam is a consultant working in Greater Manchester and the clinical lead for virtual wards across the ICS. Here she describes...

  25. Vortioxetine for treating major depressive episodes (TA367)

    Evidence-based recommendations on vortioxetine (Brintellix) for treating major depressive episodes in adults.

  26. Interim methods guide for developing good practice guidance (PMG15)

    Interim methods guide for developing good practice guidance

  27. Helping to prevent winter deaths and illnesses associated with cold homes

    A quick guide for home care managers on preventing deaths and illnesses associated with cold homes.

  28. Building independence through planning for transition

    NICE social care quick guide - building independence through planning for transition.

  29. How voluntary and community sector (VCS) organisations can help us develop guidance

    Support for organisations who contribute to developing our guidance

  30. High-sensitivity troponin tests for the early rule out of NSTEMI (DG40)

    Evidence-based recommendations on high-sensitivity troponin tests for the early rule out of NSTEMI (non-ST-segment elevation myocardial infarction)

  31. HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiography (MTG32)

    Evidence-based recommendations on HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiography.

  32. Assessment and diagnosis of autism: what to expect

    Guide for young people and their families about being assessed for autism

  33. Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer (DG58)

    Evidence-based recommendations on tumour profiling tests (EndoPredict, ICH4+C, MammaPrint, Oncotype DX and Prosigna) to guide adjuvant chemotherapy decisions in early breast cancer

  34. Digital technologies for delivering multidisciplinary weight-management services: early value assessment (HTE14)

    Early value assessment (EVA) guidance on digital technologies for delivering multidisciplinary weight-management services....

  35. Transition from children's to adults' services

    NICE's impact on transition from children’s to adults’ services

  36. Roxadustat for treating symptomatic anaemia in chronic kidney disease (TA807)

    Evidence-based recommendations on roxadustat (Evrenzo) for treating symptomatic anaemia associated with chronic kidney disease in adults.

  37. Improving the care of patients discharged following a pulmonary embolism, in line with NICE Guidelines (NG158)

    provided on discharge we were able to change our practice in line with NICE guidelines to ensure the safest possible...

  38. Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel (DG11)

    Evidence-based recommendations on faecal calprotectin tests for distinguishing between inflammatory bowel diseases (such as Crohn’s disease and ulcerative

  39. QuikRead go for C-reactive protein testing in primary care (MIB78)

    NICE has developed a medtech innovation briefing (MIB) on the QuikRead go for C-reactive protein testing in primary care

  40. Discussing and planning medicines support

    A quick guide for home care managers providing medicines support.

  41. Physical activity for children and young people (PH17)

    This guideline covers promoting physical activity for children and young people aged under 18 at home, preschool, school and in the community. It includes raising awareness of the benefits of physical activity, listening to what children and young people want, planning and providing spaces and facilities, and helping families build physical activity into their daily lives.

  42. Oral azacitidine for maintenance treatment of acute myeloid leukaemia after induction therapy (TA827)

    Evidence-based recommendations on azacitidine (Onureg) for maintenance treatment of acute myeloid leukaemia after induction therapy in adults.

  43. Human and animal bites: antimicrobial prescribing (NG184)

    This guideline sets out an antimicrobial prescribing strategy for human and animal bites (excluding insect bites) in adults, young people and children aged 72 hours and over. It aims to optimise antibiotic use and reduce antibiotic resistance.

  44. Alere Afinion CRP for C-reactive protein testing in primary care (MIB81)

    NICE has developed a medtech innovation briefing (MIB) on the Alere Afinion CRP for C-reactive protein testing in primary care

  45. Care and support of people growing older with learning disabilities (NG96)

    This guideline covers care and support for adults with learning disabilities as they grow older. It covers identifying changing needs, planning for the future, and delivering services including health, social care and housing. It aims to support people to access the services they need as they get older.

  46. NATROX oxygen wound therapy for managing diabetic foot ulcers and complex or chronic non-healing wounds (MIB208)

    NICE has developed a medtech innovation briefing (MIB) on NATROX oxygen wound therapy for managing diabetic foot ulcers and complex or chronic non-healing wounds .

  47. NICE visualisation of treatment options incorporating technology appraisals: interim process guide (PMG38)

    NICE visualisation of treatment options incorporating technology appraisals: interim process guide

  48. Teriflunomide for treating relapsing–remitting multiple sclerosis (TA303)

    Evidence-based recommendations on teriflunomide (Aubagio) for treating relapsing–remitting multiple sclerosis in adults.

  49. NICE impact diagnostic pathology

    Find out more about the progress made in implementing NICE guidance on diagnostic pathology

  50. Pembrolizumab with carboplatin and paclitaxel for untreated metastatic squamous non-small-cell lung cancer (TA770)

    Evidence-based recommendations on pembrolizumab (Keytruda) with carboplatin and paclitaxel for adults with untreated metastatic squamous non-small-cell lung cancer.